Use of heterocyclic compound in preparing drug for preventing or treating iga nephropathy

TW202629161APending Publication Date: 2026-07-16SHANGHAI MEIYUE BOITECH DEVELOPMENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
SHANGHAI MEIYUE BOITECH DEVELOPMENT CO LTD
Filing Date
2025-10-27
Publication Date
2026-07-16

Smart Images

  • Figure TWG2TA001068886_001
    Figure TWG2TA001068886_001
  • Figure TWG2TA001068886_002
    Figure TWG2TA001068886_002
  • Figure TWG2TA001068886_003
    Figure TWG2TA001068886_003
Patent Text Reader

Abstract

The present invention discloses the use of a heterocyclic compound in preparing drug for preventing or treating IgA nephropathy. Specifically, the invention discloses the use of compound A or a pharmaceutically acceptable salt thereof in preparing drug for treating and / or preventing IgA nephropathy. Compound A of the invention has good therapeutic effects on IgA nephropathy.
Need to check novelty before this filing date? Find Prior Art